Literature DB >> 16719999

The management of aspirin in transurethral prostatectomy: current practice in the UK.

Mohamed Khalid Enver1, Ivan Hoh, Frank I Chinegwundoh.   

Abstract

INTRODUCTION: Stopping aspirin prior to transurethral prostatectomy (TURP) may minimise peri-operative blood loss, but it may also increase the risk of a significant cardiovascular event. There are no guidelines on the management of aspirin in TURP. This study sought to determine the variation in the peri-operative management of transurethral prostatectomy (TURP) patients that are taking aspirin.
MATERIALS AND METHODS: A questionnaire was sent to 444 consultant urologists in the UK from a list obtained from the British Association of Urologists. This resulted in 290 anonymous replies (65%), of which 287 were suitable for analysis.
RESULTS: Of these 287 urologists, 178 (62%) ask patients to stop aspirin prior to TURP. Aspirin is stopped 9.8 days (median, 10 days; range, 2-30 days) prior to surgery, and recommenced 8.8 days (median, 7 days; range, 1-42 days) after surgery. In those that stop aspirin, 62% will stop aspirin in all patients, regardless of the indication, and 40% will cancel a TURP if aspirin use has inadvertently continued. Of the 287 urologists, 109 (38%) do not stop aspirin.
CONCLUSIONS: There is a wide variation in the management of aspirin in TURP patients in the UK. Aspirin is being stopped in patients at high risk of serious cardiovascular disease, often for longer than necessary. There is a need for multidisciplinary guidelines to reduce variation in practice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16719999      PMCID: PMC1963700          DOI: 10.1308/003588406X95084

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  30 in total

Review 1.  Over-the-counter analgesics and antipyretics: a critical assessment.

Authors:  E V Hersh; P A Moore; G L Ross
Journal:  Clin Ther       Date:  2000-05       Impact factor: 3.393

2.  Stop those antiplatelet drugs before surgery!

Authors:  S Mak; P Amoroso
Journal:  BJU Int       Date:  2003-05       Impact factor: 5.588

3.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

4.  Risk assessment of hemorrhagic complications associated with nonsteroidal antiinflammatory medications in ambulatory pain clinic patients undergoing epidural steroid injection.

Authors:  Terese T Horlocker; Zahid H Bajwa; Zubaira Ashraf; Sajid Khan; Jack L Wilson; Naveed Sami; Christine Peeters-Asdourian; Christopher A Powers; Darrell R Schroeder; Paul A Decker; Carol A Warfield
Journal:  Anesth Analg       Date:  2002-12       Impact factor: 5.108

5.  Combined therapy with clopidogrel and aspirin significantly increases the bleeding time through a synergistic antiplatelet action.

Authors:  D A Payne; P D Hayes; C I Jones; P Belham; A R Naylor; A H Goodall
Journal:  J Vasc Surg       Date:  2002-06       Impact factor: 4.268

6.  Randomised trials of secondary prevention programmes in coronary heart disease: systematic review.

Authors:  F A McAlister; F M Lawson; K K Teo; P W Armstrong
Journal:  BMJ       Date:  2001-10-27

7.  The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy--a prospective, randomized, double-blind, placebo-controlled study.

Authors:  J D Nielsen; A Holm-Nielsen; J Jespersen; C C Vinther; I W Settgast; J Gram
Journal:  Scand J Urol Nephrol       Date:  2000-06

8.  Acetylsalicylic acid-induced prolongation of bleeding time in healthy men.

Authors:  J H Dybdahl; L N Daae; C Eika; H C Godal; S Larsen
Journal:  Scand J Haematol       Date:  1981-01

9.  Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

Authors:  M Hamberg; J Svensson; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

10.  Effect of incremental doses of aspirin on bleeding time, platelet aggregation and thromboxane production in patients with cerebrovascular disease.

Authors:  A H Boss; G Boysen; J S Olseen
Journal:  Eur J Clin Invest       Date:  1985-12       Impact factor: 4.686

View more
  11 in total

1.  [ASA and clopidogrel for urological operations. Perioperative management].

Authors:  C Fischer; G Lümmen
Journal:  Urologe A       Date:  2013-11       Impact factor: 0.639

2.  Is preoperative withdrawal of aspirin necessary in patients undergoing elective inguinal hernia repair?

Authors:  Wilson Ong; Tong Shen; Wee Boon Tan; Davide Lomanto
Journal:  Surg Endosc       Date:  2016-04-29       Impact factor: 4.584

3.  Incidence and risk factors of renal hematoma: a prospective study of 1,300 SWL treatments.

Authors:  M J Schnabel; M Gierth; C G Chaussy; K Dötzer; M Burger; H M Fritsche
Journal:  Urolithiasis       Date:  2014-01-14       Impact factor: 3.436

4.  Risks and complications of transurethral resection of bladder tumor among patients taking antiplatelet agents for cardiovascular disease.

Authors:  Stefano Picozzi; Carlo Marenghi; Cristian Ricci; Giorgio Bozzini; Stefano Casellato; Luca Carmignani
Journal:  Surg Endosc       Date:  2013-09-04       Impact factor: 4.584

Review 5.  Prevention and management of TURP-related hemorrhage.

Authors:  Liam E Kavanagh; Gregory S Jack; Nathan Lawrentschuk
Journal:  Nat Rev Urol       Date:  2011-08-16       Impact factor: 14.432

6.  Postoperative haemorrhage following transurethral resection of the prostate (TURP) and photoselective vaporisation of the prostate (PVP).

Authors:  Mark Lynch; Seshadri Sriprasad; Kesavapillai Subramonian; Peter Thompson
Journal:  Ann R Coll Surg Engl       Date:  2010-06-02       Impact factor: 1.951

7.  Photoselective vaporization of the prostate in men taking clopidogrel.

Authors:  Daniel M G Spernat; Tania A Hossack; Henry H Woo
Journal:  Urol Ann       Date:  2011-05

8.  Antiplatelet drugs and the perioperative period: What every urologist needs to know.

Authors:  Pawan Vasudeva; Apul Goel; Vengetesh K Sengottayan; Satyanarayan Sankhwar; Divakar Dalela
Journal:  Indian J Urol       Date:  2009-07

9.  [Current Practice in the Transurethral Treatment of Benign Prostatic Obstruction under Oral Anticoagulants : A Nation-wide Survey].

Authors:  Christopher Netsch; Christina Moritz; Andreas J Gross
Journal:  Urologe A       Date:  2016-06       Impact factor: 0.639

Review 10.  Risk of acute myocardial infarction after transurethral resection of prostate in elderly.

Authors:  Claudio de Lucia; Grazia Daniela Femminella; Giuseppe Rengo; Antonio Ruffo; Valentina Parisi; Gennaro Pagano; Daniela Liccardo; Alessandro Cannavo; Paola Iacotucci; Klara Komici; Carmela Zincarelli; Carlo Rengo; Pasquale Perrone-Filardi; Dario Leosco; Fabrizio Iacono; Giuseppe Romeo; Bruno Amato; Nicola Ferrara
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.